Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty – Markets Insider
|
Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty
Markets Insider MIAMI, Sept. 6, 2017 /PRNewswire/ — Longeveron LLC, a regenerative medicine company developing cellular therapies, announced today that it treated its first patient in the Company's Phase 2b clinical trial evaluating the safety and efficacy of … |
